A supportive and performance-enhancing corporate culture is the basis for our success. We place particular importance on respectful interactions and view it as our responsibility, as company management, to actively promote and ensure this culture.

Since 2020, Dr. Friedrich Sernetz has served as CEO of the MiP Pharma Group. He is supported by CFO Patric Barra, who is responsible for finance, human resources, and IT; by Dr. Jürgen Mössinger, who oversees business development, regulatory affairs, and pharmacovigilance; and by Jochen Steinhage, who leads marketing and sales.